🔎 Trials Near Me

Akèy › Sipwa › Florid › Jacksonville

Etid klinik pou Sipwa nan Jacksonville, FL

19 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Jacksonville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • Jacksonville Ctr for Clin Res, Jacksonville
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • Flourish Research, Jacksonville Center for Clinical Research, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Jacksonville Ctr Clin Res, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Jacksonville
  • Research Site, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Fleming Island Center for Clinical Research, Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • East Coast Institute for Research, LLC, Jacksonville
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • Westside Center for Clinical Research, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Northeast Research Institute (NERI), Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Jacksonville
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions - Jacksonville, Jacksonville
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • Westside Center For Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions, LLC, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Ap rekriteFaz 1
  • Jacksonville Ctr For Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT07607587

Etid Sipwa nan lòt vil

Lòt etid nan Jacksonville

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.